EUVIMEDEUVIMED entdecken
Fallbericht

Prognostic factors for wellbeing in patients with hyaline fibromatosis syndrome

Hiroshi Futagawa iD, Shiho Ito, Kenji Hosoi, Ikkei Tamada, Kiyokazu Ogata, Kentaro Fukuda, Haruka Yamanaka, Maho Kuroda, Chiharu Suda, Kenji Shimizu, Hiroshi Yoshihashi

Pediatrics International · 2024

DOI: 10.1111/ped.15797 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatrics International, 2024. Verfasst von Hiroshi Futagawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Hyaline Fibromatosis Syndrome, Quality of Life. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyaline fibromatosis syndrome (HFS) is a congenital disorder characterized by subcutaneous skin nodules, congenital multiple arthrogryposis, gingival hyperplasia, and chronic pain. The intellectual ability of patients with HFS is generally normal. This syndrome arises from variants of ANTXR2 . Thus far, about 100 cases have been reported but few of these were reported from Japan.

Methods

This study reports five additional Japanese patients with genetically confirmed HFS, from unrelatd families, and discusses the clinical course and quality of life of these patients.

Results

At our last visit the ages of the patients were 3–19 years (the median age was 5 years). All the patients had arthrogryposis, skin nodules, and gingival hyperplasia, and four patients had chronic pain, all of which are distinctive, clinical characteristics of HFS. Four of the patients (80%) had pruritic skin nodules, and three experienced sleep disruptions due to pruritis. The visceral complications are an index of HFS severity. One patient in the present cohort had a mucosal abnormality without any gastrointestinal symptoms.

Conclusion

Preventive and routine management of pruritis caused by skin nodules should be shared with the patient's family. Even asymptomatic patients might have endoscopic finding, which would be a soft marker that could predict the development of protein losing enteropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaline Fibromatosis SyndromeQuality of LifeHumansFemaleMaleChild, PreschoolPrognosisChildAdolescentYoung AdultJapanReceptors, Peptide

Stichwörter der Autor:innen

ANTXR2hyalin fibromatosis syndrome

Substanzen

ANTXR2 protein, humanReceptors, Peptide

Autor:innen und Institutionen

  • Department of Clinical Genetics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Department of Nursing, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Department of Gastroenterology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Department of Plastic and Reconstructive Surgery, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Department of Pediatric Dentistry, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Division of Medical Genetics and Cytogenetics, Shizuoka Children's Hospital, Shizuoka, Japan.

ORCID-Profile: Hiroshi Futagawa

Zitieren

APA

Futagawa, H., Ito, S., Hosoi, K., Tamada, I., Ogata, K., Fukuda, K., Yamanaka, H., Kuroda, M., Suda, C., Shimizu, K., & Yoshihashi, H. (2024). Prognostic factors for wellbeing in patients with hyaline fibromatosis syndrome. Pediatrics International. https://doi.org/10.1111/ped.15797

Vancouver

Futagawa H, Ito S, Hosoi K, Tamada I, Ogata K, Fukuda K, et al. Prognostic factors for wellbeing in patients with hyaline fibromatosis syndrome. Pediatrics International. 2024. doi:10.1111/ped.15797

BibTeX
@article{Futagawa2024,
  author = {Futagawa, Hiroshi and Ito, Shiho and Hosoi, Kenji and Tamada, Ikkei and Ogata, Kiyokazu and Fukuda, Kentaro and Yamanaka, Haruka and Kuroda, Maho and Suda, Chiharu and Shimizu, Kenji and Yoshihashi, Hiroshi},
  title = {Prognostic factors for wellbeing in patients with hyaline fibromatosis syndrome},
  journal = {Pediatrics International},
  year = {2024},
  doi = {10.1111/ped.15797}
}
Kostenlos starten →